N−stearoyl valine Eicosanoyl−EA Glabrol Phosphoglycolic acid O−Phospho−4−hydroxy−L−threonine 1−(Malonylamino)cyclopropanecarboxylic acid Phosphohydroxypyruvic acid Aspartyl−Histidine 2−Aminoethylphosphonic acid 2−Methoxybenzenethiol 3−Hydroxynitrazepam 2−Butanone, 4−[6−(sulfooxy)−2−naphthalenyl]− 2−[(Ethylthio)methyl]furan (R)−(+)−2−Pyrrolidone−5−carboxylic acid Oxoglutaric acid N−Acetyl−L−aspartic acid b−D−Glucopyranosiduronic acid Phenethylamine glucuronide S−Lactoylglutathione 2,7−Anhydro−alpha−N−acetylneuraminic acid Fructoselysine Voriconazole N−Desmethylzolmitriptan Streptamine phosphate N−(1−Deoxy−1−fructosyl)valine Hydroxypropionylcarnitine Mannopine N−(1−Deoxy−1−fructosyl)isoleucine N−(1−Deoxy−1−fructosyl)leucine hept−2−enedioic acid L−Ascorbic acid−2−glucoside Ethyl glucuronide 3−Hydroxyadipic acid Methyl5−(but−3−en−1−yl)amino−1,3,4−oxadiazole−2−carboxylate 3−Acrylamidopropyl trimethylammonium Alanyl−Arginine Mimosine 3−(1−Hydroxymethyl−1−propenyl)pentanedioic acid Diethyl Oxalpropionate Citrinin Graveolinine 1−(Indol−3−yl)propanol 3−phosphate Scandinone Monoglyceride citrate (R)−2−Hydroxybutane−1,2,4−tricarboxylate 4−Carboxy−4−hydroxy−2−oxoadipate Acetyl−D−carnitine Glycerol 1−propanoate diacetate N−(2−Hydroxyethyl)iminodiacetic acid Castanospermine Petunidin Pelargonidin SC−514 Flupyrsulfuron−methyl sodium 2−C−Methyl−D−erythritol 2,4−cyclodiphosphate erythro−8,10−Heptacosanediol OH−Diaponeurosporene glucoside ester PA(12:0/15:0) 4−Carboxy−4'−sulfoazobenzene Aminomalonic acid 3,5−DINITROCATECHOL (OR−486) N−Acetylaspartylglutamic acid 2−Aminoadenosine Ceriporic acid B 2−Fluorobenzoate Inosine Allopurinol−1−ribonucleoside Hypoxanthine gamma−Glutamyl−beta−aminopropiononitrile 1,5−Dibutyl methyl hydroxycitrate Ceriporic acid A 1−O−(2R−hydroxy−octadecyl)−sn−glycerol O−6−deoxy−a−L−galactopyranosyl−(1−>2)−O−b−D−galactopyranosyl−(1−>3)−2−(acetylamino)−1,5−anhydro−2−deoxy−D−arabino−Hex−1−enitol Bosentan N−methylundec−10−enamide (3R,6S)−3−Hydroxy−1,7−dioxaspiro[5.5]undecane Gabapentin 2−octenal 7−undecynoic acid 12−amino−dodecanoic acid 2−Dodecylbenzenesulfonic acid N−Undecylbenzenesulfonic acid Ro 31−7549 cis−Resveratrol 3−sulfate 9−B1−PhytoP Kynurenic acid Dibutyl phthalate Phthalic acid Uridine N−Methyl−4−pyridone−3−carboxamide dihydrocapsaicin Type IV cyanolipid 16:0 ester N−goshuyoyl lysine cis− and trans−5−Ethyl−4−methyl−2−(2−butyl)−thiazoline Ethyl 3−(N−butylacetamido)propionate 7−oxo−8−amino−nonanoic acid (E)−2−Butenyl−4−methyl−threonine PELLETIERINE Methylthiobenzoic acid Niacinamide (S,Z)−Lyratol acetate Coutaric acid Chrycolide Itaconic acid 4−(4−Deoxy−alpha−D−gluc−4−enuronosyl)−D−galacturonate 4−Nitroquinoline−1−oxide Leu−Leu−Tyr lipoamide Baclofen Propionylcarnitine 3,4−Dihydro−2H−1−benzopyran−2−one 3−(4−Methyl−3−pentenyl)thiophene L−Histidine D−(−)−Arabinose trans−2−[(Dimethylamino)methylimino]−5−[2−(5−nitro−2− furyl)−vinyl]−1,3,4−oxadiazole N−Acetylmuramoyl−Ala KINETIN RIBOSIDE (E)−C−HDMAPP Cystamine L−Acetylcarnitine DL−Acetylcarnitine Butyrylcarnitine 2−Carboxy−4−dodecanolide Chrycorin allopurin...

No abstract

Purpose. The purpose of this study was to quantify the characteristics of the tilt and decentration of the IOL after trans-scleral suture fixation surgery in congenital ectopia lentis (CEL) patients. Methods. The clinical characteristics of 70 CEL patients at Zhongshan Ophthalmic Center in China were retrospectively analyzed. The tilt and decentration of intraocular lens (IOL) were measured by using a Pentacam and compared between different axial length (AL) subgroups. The correlation between IOL tilt, decentration, and ocular characteristics was investigated using Spearman’s correlation analysis. Results. The postoperative IOL position of CEL patients was mainly located nasally inferiorly. The average tilt of the IOL in CEL patients was less than 7° (for temporal: 2.21 ± 1.53°, for nasal: −1.84 ± 2.04°, for superior: 2.22 ± 2.18°, and for inferior: −1.70 ± 1.62°), and the average decentration of the IOL in CEL patients was larger than 0.4 mm (for temporal: 0.49 ± 0.38 mm, for nasal: −0.69 ± 0.46 mm, for superior: 0.72 ± 0.58 mm, and for inferior: −0.68 ± 0.54 mm). The decentration of CEL patients in the AL ≥ 26 subgroup was greater than those with AL < 24 mm and AL 24 to 26 mm subgroups (for superior: 0.72 ± 0.28 mm vs. 0.46 ± 0.25 mm and 0.48 ± 0.22 mm, all P < 0.05 ; for inferior: -0.94 ± 0.56 mm vs. −0.44 ± 0.26 mm and -0.44 ± 0.46 mm, all P < 0.05 ). IOL decentration was positively correlated with AL (for superior: r = 0.44, P = 0.019 ; for inferior: r = 0.54, P = 0.006 ). IOL tilt was positively correlated with AL on the superior side (r = 0.38, P = 0.041 ). Conclusions. The extent of IOL decentration after trans-scleral suture fixation was great in CEL patients, and the IOL decentration in CEL patients was significantly associated with AL.